Carboplatin
Ovarian Sex Cord-Stromal Tumor
Beihua KongSmall moleculePhase 3Active
BB
68/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 54/ 100
- Competitive Position
- 95/ 100
Competitive context
3 Active assets in the Ovarian Sex Cord-Stromal Tumor cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
ETOPOSIDE Beihua Kong | Phase 3 | BB |
BLEOMYCIN Beihua Kong | Phase 3 | BB |
CIS-DIAMMINEDICHLOROPLATINUM II Beihua Kong | Phase 3 | BB |
FULVESTRANT Frederic Amant | Phase 2 | B |
7-hydroxystaurosporine National Cancer Institute (NCI) | Phase 1 | CC |
View all 9 →
Same molecule, other indications
Carboplatin is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →